PORTLAND, Maine --(BUSINESS WIRE)--Feb. 17, 2022-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release fourth quarter and full-year 2021 results after the market closes on Thursday, February 24, 2022 .

Long-time Nestlé S.A. executive to manage global growth for Covetrus portfolio PORTLAND, Maine --(BUSINESS WIRE)--Jan. 26, 2022-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of César França as President, Global Proprietary

Covetrus Pulse ™ will unite best of Covetrus offerings into all-in-one cloud platform PORTLAND, Maine --(BUSINESS WIRE)--Jan. 12, 2022-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the launch of Covetrus Pulse™, an innovative cloud-based

PORTLAND, Maine --(BUSINESS WIRE)--Jan. 5, 2022-- Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that the Company will participate in the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022 .

The next step in the company’s strategic plan, as well as swift moves to address regional pressures Accelerating into 2022, in accordance with the company’s three-year strategic plan, with a new Northern European leadership team and reset for the company’s German and U.K.

Third quarter GAAP net sales of $1.16 billion , an increase of 3% year-over-year; non-GAAP organic net sales increased 3% year-over-year Third quarter GAAP net loss attributable to Covetrus of $(4) million versus GAAP net loss attributable to Covetrus of $(35) million in the prior year period;

PORTLAND, Maine --(BUSINESS WIRE)--Oct. 26, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2021 results after the market closes on Thursday, November 4 , 2021.

Second quarter GAAP net sales of $1.19 billion , an increase of 16% year-over-year; non-GAAP organic net sales increased 12% year-over-year Second quarter GAAP net loss attributable to Covetrus of $31 million versus GAAP net income of $54 million in the prior year period; second quarter non-GAAP

ESG commitments help illustrate company’s culture and benchmark future goals PORTLAND, Maine --(BUSINESS WIRE)--Aug. 5, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today released its first Environmental, Social and Governance report since forming just

Scholarships aim to help underrepresented students studying veterinary medicine or veterinary pharmacy PORTLAND, Maine --(BUSINESS WIRE)--Aug. 3, 2021-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, announced two new scholarships with the goal of increasing